Rockbridge Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Rockbridge Investment Management's PFE Position: Q1 2024 in Review
Rockbridge Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 4,629 shares — an estimated $133K sold.
Rockbridge Investment Management first reported a position in PFE in Q2 2020 and held it in 14 quarters. The position peaked at $478K in Q1 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Rockbridge Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Rockbridge Investment Management sold 4,629 Pfizer shares in Q1 2024, an estimated $133K.
- Rockbridge Investment Management first reported a position in Pfizer in Q2 2020 and held it in 14 quarters.
- Rockbridge Investment Management's Pfizer position peaked at $478K in Q1 2022.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.